Plasma Carboxylesterase 1 Predicts Methylphenidate Exposure: A Proof‐of‐Concept Study Using Plasma Protein Biomarker for Hepatic Drug Metabolism-Reference-Cited by-同舟云学术

Plasma Carboxylesterase 1 Predicts Methylphenidate Exposure: A Proof‐of‐Concept Study Using Plasma Protein Biomarker for Hepatic Drug Metabolism

Author:

Shi Jian¹,Xiao Jingcheng²,Wang Xinwen³,Jung Sun Min²,Bleske Barry E.⁴,Markowitz John S.⁵,Patrick Kennerly S.⁶,Zhu Hao‐Jie¹^ORCID

Affiliation:

1. Department of Clinical Pharmacy University of Michigan Ann Arbor Michigan USA

2. Department of Pharmaceutical Sciences University of Michigan Ann Arbor Michigan USA

3. Department of Pharmaceutical Sciences Northeast Ohio Medical University Rootstown Ohio USA

4. Department of Pharmacy Practice and Administrative Sciences The University of New Mexico Albuquerque New Mexico USA

5. Department of Pharmacotherapy and Translational Research University of Florida Gainesville Florida USA

6. Department of Drug Discovery and Biomedical Sciences Medical University of South Carolina Charleston South Carolina USA

Funder

National Institute on Alcohol Abuse and Alcoholism

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

Reference43 articles.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献